Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00767832 · ClinicalTrials.gov registry record
Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 60
- Enrollment target
NCT00767832: Completed study, sponsored by Stanford University.
NCT00767832 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00767832 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the coagulation changes that occur in patients undergoing elective Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-06 |
What the finished NCT00767832 record still lists
NCT00767832 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00767832 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00767832 about?
NCT00767832 is a clinical study titled "Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.". The purpose of the study is to assess the coagulation changes that occur in patients undergoing elective Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and relate...
What is the current status of trial NCT00767832?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2008-08. Estimated completion is 2009-06.
Who is sponsoring clinical trial NCT00767832?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia